HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Type III juvenile pityriasis rubra pilaris: a successful treatment with infliximab.

AuthorsM Ruzzetti, R Saraceno, I Carboni, M Papoutsaki, S Chimenti
JournalJournal of the European Academy of Dermatology and Venereology : JEADV (J Eur Acad Dermatol Venereol) Vol. 22 Issue 1 Pg. 117-8 (Jan 2008) ISSN: 1468-3083 [Electronic] England
PMID18181990 (Publication Type: Case Reports, Letter)
Chemical References
  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal
  • Infliximab
Topics
  • Adult
  • Anti-Inflammatory Agents (therapeutic use)
  • Antibodies, Monoclonal (therapeutic use)
  • Female
  • Humans
  • Infliximab
  • Pityriasis Rubra Pilaris (classification, drug therapy, pathology)
  • Skin (pathology)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: